CRDC Insights

Cancer nanotechnology data from the caNanoLab are now available through the CRDC’s General Commons (GC). These data are publicly accessible for exploration, access, and reuse. This migration to the CRDC provides an opportunity for users to integrate them with other data types, such as genomics and imaging data that are also shared through the CRDC.

The National Institutes of Health (NIH) has announced a call for abstracts for an NIH-supported special track at Intelligent Systems for Molecular Biology (ISMB) 2026, a premier international conference in computational biology and bioinformatics. The conference will be held July 12–16, 2026, in Washington, DC.  The NIH-sponsored track, titled Social and Technical Infrastructure to Advance Health Research, is scheduled for Monday, July 13, from 11:00 AM to 6:00 PM (ET).

The CRDC team, whether engaged in activities specific to the CRDC Data Commons, NCI Cloud Resources, or CRDC’s Core Services, remains focused on advancing its mission of making data and resources securely accessible to the cancer research community. The team has provided updates. 

The Proteomic Data Commons (PDC) has upgraded its portal with new features that make it easier for researchers to explore proteomic data and link it with other cancer research data types. This updated 2.0 version enhances navigation, adds more information for each study, and offers clearer connections to related study data in the CRDC’s Genomic Data Commons (GDC) and Imaging Data Commons (IDC), as well as the Cancer Imaging Archive (TCIA).   

The Cancer Research Data Commons (CRDC) is committed to supporting the research community by making data from many NCI-funded programs accessible through CRDC’s various data commons, as well as through the NCI Cloud Resource, the Seven Bridges Cancer Genome Cloud (SB-CGC).